NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
03/15/2017
Back to search
Official data from USPTO
PHARMASYNC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
03/15/2017
Classification
Registered
Trademark type
Word
Nice classes
9
Filing date
09/29/2005
Registration date
09/18/2007
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/15/2017
Last transaction
03/15/2017
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/10/2006
First use in commerce
01/10/2006
Drawing code
4
Owner type
03
Owner location
Union, NJ, US
Examiner
SPILS, CAROL
Law office
L40
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
D. C. (pessoa física)
Representatives
Data Reduction Systems Corporation
Technical classification
Nice Classes
Class 9
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Software for drug product sample inventory management
Publications
History of USPTO decisions and trademark events.
32 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
03/15/2017
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03/15/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/15/2017
E89R
TEAS SECTION 8 & 9 RECEIVED
01/17/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/17/2017
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
09/18/2016
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
09/17/2013
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/17/2013
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/17/2013
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
09/05/2013
E815
TEAS SECTION 8 & 15 RECEIVED
09/05/2013
R.PR
REGISTERED-PRINCIPAL REGISTER
09/18/2007
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
08/15/2007
ALIE
ASSIGNED TO LIE
08/15/2007
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/30/2007
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/19/2007
IUAF
USE AMENDMENT FILED
03/08/2007
EISU
TEAS STATEMENT OF USE RECEIVED
03/08/2007
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
09/26/2006
PUBO
PUBLISHED FOR OPPOSITION
07/04/2006
NPUB
NOTICE OF PUBLICATION
06/14/2006
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/16/2006
ALIE
ASSIGNED TO LIE
05/12/2006
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/05/2006
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/19/2006
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/12/2006
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/12/2006
GNRT
NON-FINAL ACTION E-MAILED
04/08/2006
CNRT
NON-FINAL ACTION WRITTEN
04/08/2006
DOCK
ASSIGNED TO EXAMINER
04/01/2006
NWAP
NEW APPLICATION ENTERED
10/04/2005
Continuous trademark protection
Get notified about every new filing that threatens PHARMASYNC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.